Santa Casa de Misericórdia de Belo Horizonte   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Belo Horizonte Brazil (1996)

Organization Overview

First Clinical Trial
2008
NCT00672347
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Andre Barreto Pereira | Santa Casa de Misericórdia de Belo Horizonte

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Diseases (Phase 3)

Coronavirus Infections (Phase 2)

Low Back Pain (Phase 3)

Neuralgia (Phase 4)

Pain, Postoperative (Phase 2)

Pneumonia (Phase 2)

Pneumonia, Viral (Phase 2)

Severe Acute Respiratory Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 11